© 2000 American Heart Association, Inc.
Cellular Biology |
ADP-Ribosyl Cyclase in Rat Vascular Smooth Muscle Cells
Properties and Regulation
From the Department of Physiology and Biophysics, Division of Nephrology and Internal Medicine (F.G.S.d.T., J.C., M.L., T.P.D.), and Departments of Anesthesiology and Department of Medicine (E.N.C.), Mayo Clinic and Foundation, Mayo Medical School, Rochester, Minn.
Correspondence to Eduardo N. Chini, MD, PhD, Mayo Clinic, 200 First St, SW, Guggenheim 9, Rochester, MN 55905. E-mail chini.eduardo{at}mayo.edu
Abstract—We investigated whether
ADP-ribosyl cyclase (ADPR-cyclase) in rat vascular smooth muscle cells
(VSMCs) has enzymatic properties that differ from the
well-characterized CD38-antigen ADPR-cyclase, expressed in HL-60 cells.
ADPR-cyclase from VSMCs, but not CD38 ADPR-cyclase from HL-60 cells,
was inhibited by gangliosides (10 µmol/L) GT1B,
GD1, and GM3. Preincubation of membranes from
CD38 HL-60 cells, but not from VSMCs, with anti-CD38 antibodies
increased ADPR-cyclase activity; CD38 antigen was detected both in
VSMCs and in HL-60 cells. ADPR-cyclase in VSMC membranes was more
sensitive than CD38 HL-60 ADPR-cyclase to inactivation by
N-endoglycosidase F and to thermal inactivation at
45°C. The specific activity of ADPR-cyclase in membranes from VSMCs
was >20-fold higher than in membranes from CD38 HL-60 cells. Most
importantly, VSMC ADPR-cyclase was inhibited by Zn2+ and
Cu2+ ions; the inhibition by Zn2+ was dose
dependent, noncompetitive, and reversible by EDTA. In contrast,
Zn2+ stimulated the activity of CD38 HL-60 ADPR-cyclase and
other known types of ADPR-cyclases. Retinoids act either via the
nuclear receptor retinoic acid receptor or retinoid X receptor,
including all-trans retinoic acid (atRA), and panagonist
9-cis-retinoic acid–upregulated VSMC ADPR-cyclase; the
stimulatory effect of atRA was blocked by actinomycin D and
cycloheximide. 1,25(OH)2–Vitamin D3
(calciferol) stimulated VSMC ADPR-cyclase dose dependently at
subnanomolar concentrations (ED50
56 pmol/L).
Oral administration of atRA to rats resulted in an increase of
ADPR-cyclase activity in aorta (+60%) and, to a lesser degree, in
myocardium of left ventricle (+18%), but atRA had no
effect on ADPR-cyclases in lungs, spleen, intestinal smooth muscle,
skeletal muscle, liver, or testis. Administration of
3,5,3'-triiodothyronine (T3) to rats resulted in an
increase of ADPR-cyclase activity in aorta (+89%), but not in liver
or brain. We conclude the following: (1) ADPR-cyclase in VSMCs has
enzymatic properties distinct from "classic" CD38 ADPR-cyclase,
especially sensitivity to inhibition by Zn2+ and
Cu2+; (2) ADPR-cyclase in VSMCs is upregulated by various
retinoids, calcitriol, and T3 in vitro; and (3)
administration of atRA and T3 increases ADPR-cyclase in
aorta in vivo. We suggest that the cADPR signaling system plays an
important role in the regulation of VSMC functions in response to
steroid superfamily hormones.
Key Words: vascular smooth muscle cells • calciferols • antibodies • ADP-ribose • retinoids
This article has been cited by other articles:
 |
|
 |
|
  T. L. Thai and W. J. Arendshorst Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine Am J Physiol Renal Physiol, July 1, 2009; 297(1): F169 - F176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gul, J.-H. Park, S.-Y. Kim, K. Y. Jang, J.-K. Chae, J.-K. Ko, and U.-H. Kim Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy Cardiovasc Res, February 15, 2009; 81(3): 582 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Thai and W. J. Arendshorst ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo Am J Physiol Renal Physiol, August 1, 2008; 295(2): F360 - F368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology Physiol Rev, July 1, 2008; 88(3): 841 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gul, S.-Y. Kim, K.-H. Park, B.-J. Kim, S.-J. Kim, M.-J. Im, and U.-H. Kim A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H77 - H88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Kim, R. Gul, S.-Y. Rah, S. H. Kim, S. K. Park, M.-J. Im, H. J. Kwon, and U.-H. Kim Molecular mechanism of ADP-ribosyl cyclase activation in angiotensin II signaling in murine mesangial cells Am J Physiol Renal Physiol, April 1, 2008; 294(4): F982 - F989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Liang and J. L. Pietrusz Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2 Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 77 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Soares, M. Thompson, T. White, A. Isbell, M. Yamasaki, Y. Prakash, F. E. Lund, A. Galione, and E. N. Chini NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells Am J Physiol Cell Physiol, January 1, 2007; 292(1): C227 - C239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Fellner and W. J. Arendshorst Angiotensin II, reactive oxygen species, and Ca2+ signaling in afferent arterioles Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1012 - F1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fritz, N. Macrez, J. Mironneau, L. H. Jeyakumar, S. Fleischer, and J.-L. Morel Ryanodine receptor subtype 2 encodes Ca2+ oscillations activated by acetylcholine via the M2 muscarinic receptor/cADP-ribose signalling pathway in duodenum myocytes J. Cell Sci., May 15, 2005; 118(10): 2261 - 2270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Deshpande, T. A. White, S. Dogan, T. F. Walseth, R. A. Panettieri, and M. S. Kannan CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L773 - L788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Fellner and W. J. Arendshorst Angiotensin II Ca2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways Am J Physiol Renal Physiol, April 1, 2005; 288(4): F785 - F791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Fellner and L. Parker Endothelin-1, superoxide and adeninediphosphate ribose cyclase in shark vascular smooth muscle J. Exp. Biol., March 15, 2005; 208(6): 1045 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Barata, M. Thompson, W. Zielinska, Y. S. Han, C. B. Mantilla, Y. S. Prakash, S. Feitoza, G. Sieck, and E. N. Chini The Role of Cyclic-ADP-Ribose-Signaling Pathway in Oxytocin-Induced Ca2+ Transients in Human Myometrium Cells Endocrinology, February 1, 2004; 145(2): 881 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Chini and F. G. S. De Toledo Nicotinic acid adenine dinucleotide phosphate: a new intracellular second messenger? Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1191 - C1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dogan, T. A. White, D. A. Deshpande, M. P. Murtaugh, T. F. Walseth, and M. S. Kannan Estrogen Increases CD38 Gene Expression and Leads to Differential Regulation of Adenosine Diphosphate (ADP)-Ribosyl Cyclase and Cyclic ADP-Ribose Hydrolase Activities in Rat Myometrium Biol Reprod, March 1, 2002; 66(3): 596 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Chini Signal Transduction in Smooth Muscle: Selected Contribution: Effect of volatile anesthetics on cADP-ribose-induced Ca2+ release system J Appl Physiol, July 1, 2001; 91(1): 516 - 521. [Abstract] [Full Text] [PDF]
|
|